Skip to content

Clinical trials

Polycythemia Vera trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Polycythemia Vera Country / region: United States Clear all

175 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20006
20014
20029
20031
20043
200512
20069
200712
20089
20099
20108
20116
20126
20133
20147
20156
20161
20172
20183
20197
20205
20215
20224
20232
20246
20254
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed107
Terminated28
Recruiting17
Active, not recruiting13
Withdrawn5
Unknown status4
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center15
National Cancer Institute (NCI)13
Fred Hutchinson Cancer Center11
Incyte Corporation6
Icahn School of Medicine at Mount Sinai5
Mayo Clinic4
Ronald Hoffman4
Roswell Park Cancer Institute4
Alliance for Clinical Trials in Oncology3
Case Comprehensive Cancer Center3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Polycythemia Vera175
Primary Myelofibrosis137
Thrombocythemia, Essential127
Myeloproliferative Disorders104
Leukemia, Myeloid, Acute73
Leukemia, Myelomonocytic, Chronic71
Precursor Cell Lymphoblastic Leukemia-Lymphoma68
Leukemia, Lymphocytic, Chronic, B-Cell66
Myelodysplastic Syndromes61
Multiple Myeloma60

Trials

Showing 1 to 25 of 175. Each trial links to its page on Pharma Observatory.

75 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.